(MENAFN- GlobeNewsWire - Nasdaq) The U.S. anti-venom market is buoyed by increased human encounters with venomous species due to urbanization and climate change. Advances in biotechnology enhance treatment efficacy and accessibility, while robust healthcare infrastructure and outdoor activities further drive demand.Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "U.S. Anti-Venom Market Size, Share & Trends Analysis Report By Species (Snake, Scorpion, Spider), By Type (Polyvalent, Monovalent), By Mode of Action (Cytotoxic, Neurotoxic), By End Use, And Segment Forecasts, 2025 - 2030" report has been added to ResearchAndMarkets's offering.
The U.S. anti-venom market size was estimated at USD 424.5 million in 2024 and is projected to reach USD 670.0 million by 2030, growing at a CAGR of 8.0% from 2025 to 2030. The market is expanding due to the rising incidence of venomous bites and stings, especially from snakes and insects.
Increased human interaction with venomous species is fueled by urbanization, deforestation, and climate change, which have impacted the habitats of these animals and brought them closer to populated areas. This trend has heightened the need for effective anti-venom treatments to reduce fatalities and long-term health complications associated with envenomation, driving the U.S. anti-venom industry.
Advancements in biotechnology significantly contribute to market growth. Innovations such as monoclonal antibody-based anti-venoms and recombinant DNA technologies have resulted in the development of more potent, safer, and targeted therapies. These improvements enhance treatment outcomes and help reduce production costs, making anti-venoms more accessible. The continuous research and development efforts by pharmaceutical companies and research institutions, particularly in the U.S., foster innovation and the introduction of advanced anti-venom products tailored to specific venom types.
The U.S. market benefits from a robust healthcare system that facilitates rapid access to anti-venom treatments in emergency settings. The prevalence of outdoor recreational activities and expanding urban development into wildlife habitats increases the likelihood of encounters with venomous species, thereby driving market demand. Moreover, the presence of key industry players and ongoing government support for pharmaceutical innovation strengthen the market's growth prospects.
![]()
U.S. Anti-Venom Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the U.S. anti-venom market report based on species, type, mode of action, and end use.
Species Outlook
Snake Common Cobra Common Krait Russell Viper Others Scorpion Spider Other
Type Outlook
Mode of Action Outlook
Cytotoxic Neurotoxic Hemotoxic Cardiotoxic Myotoxic Others
End Use Outlook
Hospitals Clinics Ambulatory Surgical Centers
Why should you buy this report?
Comprehensive Market Analysis : Gain detailed insights into the global market across major regions and segments. Competitive Landscape : Explore the market presence of key players worldwide. Future Trends : Discover the pivotal trends and drivers shaping the future of the global market. Actionable Recommendations : Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
Market intelligence to enable effective decision-making Market estimates and forecasts from 2018 to 2030 Growth opportunities and trend analyses Segment and regional revenue forecasts for market assessment Competition strategy and market share analysis Product innovation listing for you to stay ahead of the curve
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 80 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $424.5 Million |
| Forecasted Market Value (USD) by 2030 | $670 Million |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | United States |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Anti-Venom Market Variables, Trends & Scope
Chapter 4. U.S. Anti-Venom Market: Species Estimates & Trend Analysis
Chapter 5. U.S. Anti-Venom Market: Type Estimates & Trend Analysis
Chapter 6. U.S. Anti-Venom Market: Mode of Action Estimates & Trend Analysis
Chapter 7. U.S. Anti-Venom Market: End Use Estimates & Trend Analysis
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.4. Company Profiles
Boehringer Ingelheim CSL Merck & Co., Inc. Pfizer, Inc.
For more information about this report visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
CONTACT:
CONTACT:
Laura Wood,Senior Press Manager
...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
![]()
MENAFN01102025004107003653ID1110134571
Comments
No comment